Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yueren Yan
Observed name:
Y Yan
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
State Key Laboratory of Genetic Engineering
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
State Key Laboratory of Genetic Engineering
ORCID:
0000-0002-2826-2251
Observed ORCID:
0000-0002-2826-2251
OpenAlex ID:
A5084656671
Measuring the preference towards patient-centred communication with the Chinese-revised Patient–Practitioner Orientation Scale: a cross-sectional study among physicians and patients in clinical settings in Shanghai, China
2017
·
Jie Wang
, Runyu Zou
, et al.
·
BMJ Open
·
54
PDF
Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma
2025
·
Yang Zhang
, Bin Qian
, et al.
·
Journal of Clinical Oncology
·
50
RBM10 Loss Promotes EGFR -Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2023
·
Yufang Bao
, Sirui Zhang
, et al.
·
Cancer Research
·
39
Uniportal versus multiportal video-assisted thoracoscopic anatomical resection for NSCLC: a meta-analysis
2020
·
Yueren Yan
, Qingyuan Huang
, et al.
·
Journal of Cardiothoracic Surgery
·
38
PDF
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stages
2024
·
Yue Zhao
, Jian Gao
, et al.
·
Nature Communications
·
19
PDF
Genomic and transcriptomic dynamics in the stepwise progression of lung adenocarcinoma
2025
·
Fangqiu Fu
, Jun Shang
, et al.
·
Cell Research
·
18
PDF
RNA splicing alterations in lung cancer pathogenesis and therapy
2023
·
Yueren Yan
, Yunpeng Ren
, et al.
·
Cancer Pathogenesis and Therapy
·
16
Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma
2022
·
Yue Zhao
, Jun Shang
, et al.
·
Frontiers in Immunology
·
12
NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma
2021
·
Yueren Yan
, Zhendong Gao
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
10
PDF
Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features
2024
·
Wangyang Zhu
, Han Han
, et al.
·
Journal of Thoracic and Cardiovascular Surgery
·
8
Splicing Shift of RAC1 Accelerates Tumorigenesis and Defines a Potent Therapeutic Target in Lung Cancer
2025
·
Yueren Yan
, Ning Wang
, et al.
·
Advanced Science
·
5
Ten-year follow-up outcomes of resected stage II non-small cell lung cancer patients
2025
·
Wenrui Sun
, Di Li
, et al.
·
Journal of Thoracic Disease
·
4
Integrated multi-omics analysis reveals GPD1L-mediated dysregulation of glycerophospholipid metabolism facilitates the progression of lung adenocarcinoma
2026
·
Yifu Sun
, Yueren Yan
, et al.
·
Respiratory Research
·
2
A novel mouse cell line model reveals the tumor intrinsic and immune characteristics of EGFR-mutant lung cancer
2025
·
Yueren Yan
, Jun Shang
, et al.
·
Theranostics
·
2
PDF
Segmentectomy achieves comparable survival outcomes compared to lobectomy in peripheral ≤3 cm non-small cell lung cancer with occult lymph node metastases
2026
·
Yuting Chen
, Jie Wang
, et al.
·
Journal of Thoracic Disease
·
1
Integrative clinico-molecular analysis reveals actionable subtypes and biomarkers in lung adenocarcinoma
2026
·
Jun Shang
, He Jiang
, et al.
·
Cell Discovery
·
1
PDF
OA01.06: Segmentectomy Achieves Non-Inferior Survival Outcomes Compared to Lobectomy in Peripheral ≤3 cm Non-Small Cell Lung Cancer with Occult Lymph Node Metastases
2026
·
Yuting Chen
, Jie Wang
, et al.
·
Journal of Thoracic Oncology
RF1. Single-Cell Spatial Transcriptomics Identifies Clinically Relevant Epithelial Subtypes in Lung Squamous Cell Carcinoma
2026
·
Han Han
, Jun Shang
, et al.
·
Journal of Thoracic and Cardiovascular Surgery
PDF
Comprehensive immunological profiling across diverse clinical and pathological subtypes of lung adenocarcinoma
2026
·
Han Han
, Fanfan Fan
, et al.
·
Journal of the National Cancer Center
Supplementary Data from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
PDF
Supplementary Table S4 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S5 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S2 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S3 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Supplementary Table S1 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
2025
·
Yufang Bao
, Sirui Zhang
, et al.
Show more works
View as search
Works count:
50
Citation count:
279
H-index:
9
I10-index:
9
Year
Topic
Type